$58.08
-4.80-7.63%
At close: -
$58.80
0.721.24%
After Hours: 7:59 PM EDT
Comments
Loading...
Latest Novo Nordisk Stock News | NYSE:NVO | Benzinga
Get the latest news on Novo Nordisk stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Novo Nordisk performance
Categories: All
Friday, April 18, 2025
Thursday, April 17, 2025
- Eli Lilly Rallies Over 14%, Notches Best Day Since June 2000 On Oral Weight-Loss Drug Results: Analysts React
- Novo Nordisk May Lag Behind Eli Lilly In Cardiometabolic Race, Analyst Downgrades Stock
- Lilly's Diabetes Pill Clears Major Trial, Analyst Points To Global Potential
- Mark Cuban Says This Trump Healthcare Order 'Could Save Hundreds Of Billions'
- This Twin Disc Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
- Intuit To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
- Novo Nordisk shares are trading lower after B...
- This Microsoft Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
- BMO Capital Downgrades Novo Nordisk to Market...
Tuesday, April 15, 2025
- Counterfeit Ozempic Identified in US Supply Chain With Fake Labels And Needles, FDA Alerts
- Skye Bioscience's Obesity Candidate Shows 30% Weight Loss When Combined With Eli Lilly's Blockbuster Drug In Animal Models
- Eli Lilly's Mounjaro Launch Triggers Weight-Loss Drug Craze In India, Novo Nordisk Seeks To Move Up Wegovy Launch
Monday, April 14, 2025
Thursday, April 10, 2025
Wednesday, April 09, 2025
Tuesday, April 08, 2025
Monday, April 07, 2025
Wednesday, April 02, 2025
Tuesday, April 01, 2025
Monday, March 31, 2025
- Novo Nordisk Shares Data From Injectable Ozempic, Oral Weight Loss Drug
- US Stocks Likely To Open Lower After 3-Day Fall: 'Equity Drawdown Probability Hasn't Peaked Yet,' Says Goldman Sachs Analyst
- While Wall Street Panicked, These 3 Hidden Small-Caps Exploded Last Week — One Surging A Jaw-Dropping 60%
